speb/financial-data huggingface dataset:
Financial ratios for CTEK.V — annual report dated 2022-12-31
Total revenue: 9644117.647058822
Gross profit: 5729411.7647058815
Operating income: -2173529.4117647056
Net income: -2637500
Capital expenditures: 1983823.5294117646
Operating cash flow: 456617.6470588235
Depreciation & amortization: 2323529.4117647056
Net tangible assets: 813970.5882352941
Owner earnings: -2297794.1176470593
Return on net tangible assets (%): -282.2944896115628
Buffett classification: The Gruesome
Stock price: 0.1691176470588235
Shares outstanding: 29315377
Book value: 1197058.823529413
P/B ratio: 4.141607315724811
Market cap (USD): 4957747.580882353
Debt to equity: 6.954545454545447
Current ratio: 0.3113347632403894
Quick ratio: 0.3113347632403894
Interest coverage ratio: -2.4052074857607812
COGS to revenue (%): 40.59164379383959
R&D to revenue (%): 0
SG&A to revenue (%): 57.853003964623376
Free cash flow (dilution-adjusted): -1966176.4705882352
Buyback yield (%): 0
Retained earnings: -51286029.4117647
Receivables turnover: 4.83806713389893
Capitalized R&D asset: -457921.2598425197
ROCI (R&D-adjusted, %): -83.41656058687563
FCF margin (%): -20.3873132052455
Rule of 40 score: -20.3873132052455
Financial ratios for CTEK.V — annual report dated 2023-12-31
Total revenue: 10597727.272727272
Gross profit: 6352272.727272727
Operating income: 545454.5454545454
Net income: -1381060.606060606
Capital expenditures: 840909.0909090908
Operating cash flow: 2503030.3030303027
Depreciation & amortization: 1691666.6666666665
Net tangible assets: -17424.242424242424
Owner earnings: -530303.0303030303
Capex to operating income (%): 154.16666666666669
Buffett classification: The Gruesome
Stock price: 0.1893939393939394
Shares outstanding: 29315377
Book value: 303787.8787878789
P/B ratio: 18.276419576059844
Market cap (USD): 5552154.734848484
Debt to equity: 29.281795511221933
Current ratio: 0.536400882445635
Quick ratio: 0.536400882445635
Interest coverage ratio: 0.45311516677155445
COGS to revenue (%): 40.06004717992708
R&D to revenue (%): 0.06433626420759168
SG&A to revenue (%): 38.830509686182005
Free cash flow (dilution-adjusted): 1293939.3939393938
Buyback yield (%): 0
Retained earnings: -54221212.12121212
Receivables turnover: 5.460187353629976
Capitalized R&D asset: -218725.12526843234
ROCI (R&D-adjusted, %): 11.89952194573583
FCF margin (%): 12.209593251840731
Revenue growth (%): 9.887992458898227
Rule of 40 score: 22.097585710738958
Financial ratios for CTEK.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.13333333333333333
Shares outstanding: 29315377
Market cap (USD): 3908716.933333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTEK.V — quarterly report dated 2024-12-31
Capital expenditures: 279720.27972027974
Buffett classification: The Gruesome
Stock price: 0.1048951048951049
Shares outstanding: 29315377
Market cap (USD): 3075039.5454545454
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTEK.V — annual report dated 2024-12-31
Total revenue: 8242657.342657343
Gross profit: 5048951.048951049
Operating income: 768531.4685314685
Net income: 883216.7832167833
Capital expenditures: 520979.020979021
Operating cash flow: 1530069.9300699302
Depreciation & amortization: 1583916.083916084
Net tangible assets: 776223.7762237763
Owner earnings: 1946153.8461538462
Return on net tangible assets (%): 250.72072072072072
Capex to operating income (%): 67.78889899909008
Buffett classification: The Good
Stock price: 0.1048951048951049
P/E ratio: 3.4816362232779094
Shares outstanding: 29315377
Book value: 971328.6713286713
P/B ratio: 3.165807451403888
Market cap (USD): 3075039.5454545454
Debt to equity: 7.349172066234702
Current ratio: 0.6247338881362493
Quick ratio: 0.6247338881362493
Effective tax rate (%): 8.011653313911143
Interest coverage ratio: 1.2432126696832577
COGS to revenue (%): 38.74607618562823
SG&A to revenue (%): 32.71400695681683
Free cash flow (dilution-adjusted): 934965.034965035
Buyback yield (%): 0
Retained earnings: -49167132.86713287
Receivables turnover: 4.690409868682849
Capitalized R&D asset: 4568.181818181818
ROCI (R&D-adjusted, %): 12.920768831438355
Rosenberg metric: -191.153846153846
FCF margin (%): 11.34300500551455
Revenue growth (%): -22.222405516422235
Rule of 40 score: -10.879400510907685
Financial ratios for CTEK.V — quarterly report dated 2025-03-31
Total revenue: 2590909.090909091
Gross profit: 1640559.4405594405
Operating income: 510489.5104895105
Net income: 313986.013986014
Capital expenditures: 479020.979020979
Operating cash flow: 520279.7202797203
Depreciation & amortization: 353846.1538461539
Net tangible assets: 1124475.5244755244
Owner earnings: 188811.1888111888
Return on net tangible assets (%): 16.791044776119403
Capex to operating income (%): 93.83561643835617
Buffett classification: The Gruesome
Stock price: 0.24475524475524474
P/E ratio: 5.7129075445434285
Shares outstanding: 29315377
Book value: 1309790.2097902112
P/B ratio: 5.478046956753865
Market cap (USD): 7175092.2727272725
Debt to equity: 5.690336358782696
Current ratio: 0.8225750776665516
Quick ratio: 0.7859855022437003
Effective tax rate (%): 4.670912951167728
Interest coverage ratio: 3.5436893203883493
COGS to revenue (%): 36.680161943319845
SG&A to revenue (%): 29.959514170040492
Free cash flow (dilution-adjusted): 23076.923076923078
Buyback yield (%): 0
Retained earnings: -48853146.85314686
Inventory turnover: 6.410377358490566
Receivables turnover: 1.0948581560283688
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.767610129814853
FCF margin (%): 0.8906882591093118
Rule of 40 score: 0.8906882591093118
Financial ratios for CTEK.V — quarterly report dated 2025-06-30
Total revenue: 2446715.328467153
Gross profit: 1300729.9270072991
Operating income: 178102.18978102188
Net income: -333576.6423357664
Capital expenditures: 97810.21897810219
Operating cash flow: 281751.82481751824
Depreciation & amortization: 356204.37956204376
Net tangible assets: 1047445.2554744525
Owner earnings: -75182.48175182483
Return on net tangible assets (%): -7.177700348432057
Capex to operating income (%): 54.91803278688525
Buffett classification: The Good
Stock price: 0.2408759124087591
Shares outstanding: 29315377
Book value: 1229927.0072992686
P/B ratio: 5.741290451038582
Market cap (USD): 7061368.182481752
Debt to equity: 6.383976261127604
Current ratio: 0.7682403433476396
Quick ratio: 0.7484605336816571
Interest coverage ratio: 1.1401869158878504
COGS to revenue (%): 46.83770883054893
SG&A to revenue (%): 31.32458233890215
Free cash flow (dilution-adjusted): 151824.81751824816
Buyback yield (%): 0
Retained earnings: -51350364.963503644
Inventory turnover: 14.811320754716979
Receivables turnover: 1.047827446076899
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.658531270429288
FCF margin (%): 6.205250596658711
Revenue growth (%): -5.5653732872326875
Rule of 40 score: 0.6398773094260237
Financial ratios for CTEK.V — quarterly report dated 2025-09-30
Total revenue: 2361151.0791366906
Gross profit: 1358992.8057553957
Operating income: 252517.9856115108
Net income: 253237.41007194246
Capital expenditures: 192805.75539568346
Operating cash flow: 696402.8776978417
Depreciation & amortization: 384892.0863309353
Net tangible assets: 1243884.892086331
Owner earnings: 445323.7410071943
Return on net tangible assets (%): 35.801041064198955
Capex to operating income (%): 76.35327635327634
Buffett classification: The Gruesome
Stock price: 0.30935251798561153
P/E ratio: 38.81408348020997
Shares outstanding: 29315377
Book value: 1413669.0647482015
P/B ratio: 6.415069776081425
Market cap (USD): 9068785.690647483
Debt to equity: 5.211704834605598
Current ratio: 0.8297872340425533
Quick ratio: 0.8151711378353377
Effective tax rate (%): 5.630026809651476
Interest coverage ratio: 1.6175115207373272
COGS to revenue (%): 42.474101157830596
SG&A to revenue (%): 30.560633759902505
Free cash flow (dilution-adjusted): 470503.5971223022
Buyback yield (%): 0
Retained earnings: -50361870.503597125
Inventory turnover: 17.645569620253166
Receivables turnover: 0.936376604850214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8524860059269015
FCF margin (%): 19.926873857404026
Revenue growth (%): -3.497106849126895
Rule of 40 score: 16.429767008277132
Financial ratios for CTEK.V — annual report dated 2025-12-31
Total revenue: 10047445.255474452
Gross profit: 5818248.175182481
Operating income: 1585401.4598540145
Net income: 686131.3868613138
Capital expenditures: 1009489.0510948905
Operating cash flow: 2020437.9562043794
Depreciation & amortization: 1478102.1897810218
Net tangible assets: 1781021.8978102189
Owner earnings: 1154744.5255474448
Return on net tangible assets (%): 64.83606557377047
Capex to operating income (%): 63.67403314917127
Buffett classification: The Good
Stock price: 0.3284671532846715
P/E ratio: 14.033957074468086
Shares outstanding: 29315377
Book value: 1942335.7664233577
P/B ratio: 4.957504565952649
Market cap (USD): 9629138.430656934
Debt to equity: 3.741826381059752
Current ratio: 0.9042891183478952
Quick ratio: 0.8826449563145353
Effective tax rate (%): 8.292682926829269
Interest coverage ratio: 2.567375886524823
COGS to revenue (%): 42.09226298583364
SG&A to revenue (%): 27.4173628768616
Free cash flow (dilution-adjusted): 896350.3649635036
Buyback yield (%): 0.09096477478924002
Retained earnings: -50671532.84671532
Inventory turnover: 53.1559633027523
Receivables turnover: 3.9294890094204966
Capitalized R&D asset: 2250
ROCI (R&D-adjusted, %): 22.946121805817533
FCF margin (%): 8.92117689792953
Revenue growth (%): 21.895704719847853
Rule of 40 score: 30.816881617777383
Financial ratios for CTEK.V — quarterly report dated 2025-12-31
Total revenue: 2500729.927007299
Gross profit: 1429197.0802919706
Operating income: 621897.8102189781
Net income: 437956.204379562
Capital expenditures: 132846.71532846714
Operating cash flow: 215328.46715328464
Depreciation & amortization: 361313.8686131387
Net tangible assets: 1781021.8978102189
Owner earnings: 666423.3576642335
Return on net tangible assets (%): 37.41803278688525
Capex to operating income (%): 21.361502347417836
Buffett classification: The Great
Stock price: 0.3284671532846715
P/E ratio: 14.337545588574944
Shares outstanding: 29315377
Book value: 1942335.7664233577
P/B ratio: 4.957504565952649
Market cap (USD): 9629138.430656934
Debt to equity: 3.741826381059752
Current ratio: 0.9042891183478952
Quick ratio: 0.8826449563145353
Effective tax rate (%): 3.3816425120772946
Interest coverage ratio: 4.076555023923445
COGS to revenue (%): 42.8488032691185
SG&A to revenue (%): 17.834208990075894
Free cash flow (dilution-adjusted): 319708.02919708024
Buyback yield (%): 0
Retained earnings: -50671532.84671532
Inventory turnover: 13.46788990825688
Receivables turnover: 0.9780188409934341
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.016827177479097
FCF margin (%): 12.784588441331
Revenue growth (%): 5.911474666061718
Rule of 40 score: 18.696063107392717
Financial ratios for CVB.AX — annual report dated 2024-06-30
Total revenue: 6526898
Gross profit: 3007404
Operating income: -23937772
Net income: -23101017
Capital expenditures: 83444
Depreciation & amortization: 2829195
Net tangible assets: 577463
Owner earnings: -20355266
Return on net tangible assets (%): -3524.9472260560415
Buffett classification: The Gruesome
Stock price: 0.10666666666666667
Shares outstanding: 483846192
Book value: 38919609
P/B ratio: 1.3260734577266695
Market cap (USD): 51610260.480000004
Debt to equity: 0.4093908548772933
Current ratio: 2.860754373781642
Quick ratio: 1.5429695292202008
Interest coverage ratio: -14.562167811450433
COGS to revenue (%): 53.922920198844835
R&D to revenue (%): 11.71879811818723
SG&A to revenue (%): 276.0607412587113
Free cash flow (dilution-adjusted): -22184133
Buyback yield (%): 3.500631431031289
Retained earnings: -92388806
Inventory turnover: 0.32705049019557736
Receivables turnover: 1.6717709369081666
Capitalized R&D asset: 1158973.36
ROCI (R&D-adjusted, %): -41.94444506409639
Rosenberg metric: -2.3561801267578817
FCF margin (%): -339.88784565041465
Revenue growth (%): -18.97279183751401
Rule of 40 score: -358.86063748792867
Financial ratios for DTD2.DE — annual report dated 2021-06-30
Total revenue: 12425000
Gross profit: 4839285.714285715
Operating income: -502380.9523809524
Net income: 267857.14285714284
Capital expenditures: 88095.23809523809
Operating cash flow: 866666.6666666667
Depreciation & amortization: 1847619.0476190476
Net tangible assets: -232142.85714285716
Owner earnings: 2027380.9523809522
Return on net tangible assets (%): -873.3333333333333
Buffett classification: The Gruesome
Stock price: 4.523809523809524
P/E ratio: 104.87886844444445
Shares outstanding: 6209933
Book value: 15230952.38095238
P/B ratio: 1.8444384398937004
Market cap (USD): 28092554.04761905
Debt to equity: 0.6445208691574177
Current ratio: 0.5816614160172442
Quick ratio: 0.5816614160172442
Interest coverage ratio: -2.2810810810810813
COGS to revenue (%): 61.05202644438057
SG&A to revenue (%): 6.764395899204753
Free cash flow (dilution-adjusted): 777380.9523809524
Buyback yield (%): 0
Retained earnings: -40476.19047619048
Receivables turnover: 11.860227272727272
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.020298736116431
FCF margin (%): 6.256587141899013
Rule of 40 score: 6.256587141899013
Financial ratios for DTD2.DE — annual report dated 2022-06-30
Total revenue: 11545833.333333334
Gross profit: 4281250
Operating income: 126041.66666666667
Net income: 28125
Capital expenditures: 44791.66666666667
Operating cash flow: 1538541.6666666667
Depreciation & amortization: 1552083.3333333335
Net tangible assets: 182291.6666666667
Owner earnings: 1535416.6666666667
Return on net tangible assets (%): 842.2857142857142
Capex to operating income (%): 35.537190082644635
Buffett classification: The Good
Stock price: 2.4583333333333335
P/E ratio: 542.7941437037038
Shares outstanding: 6209933
Book value: 13354166.666666668
P/B ratio: 1.1431701934477378
Market cap (USD): 15266085.291666668
Debt to equity: 0.5252730109204368
Current ratio: 0.6264407963674467
Quick ratio: 0.6264407963674467
Effective tax rate (%): 93.26683291770573
Interest coverage ratio: 0.7423312883435582
COGS to revenue (%): 62.91952363767594
SG&A to revenue (%): 6.0267051605918445
Free cash flow (dilution-adjusted): 1493750
Buyback yield (%): 0
Retained earnings: -19791.666666666668
Receivables turnover: 27.166666666666668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6216605014385532
FCF margin (%): 12.93756766510285
Revenue growth (%): -7.07578806170355
Rule of 40 score: 5.861779603399301
Financial ratios for DTD2.DE — annual report dated 2023-06-30
Total revenue: 12205434.782608695
Gross profit: 4882608.695652174
Operating income: 316304.3478260869
Net income: 479347.8260869565
Capital expenditures: 41304.34782608695
Operating cash flow: 305434.7826086956
Depreciation & amortization: 1365217.3913043477
Net tangible assets: 705434.7826086957
Owner earnings: 1803260.8695652173
Return on net tangible assets (%): 255.62403697996916
Capex to operating income (%): 13.058419243986256
Buffett classification: The Great
Stock price: 2.076086956521739
P/E ratio: 26.895628185941042
Shares outstanding: 6209933
Book value: 14217391.304347824
P/B ratio: 0.9068021429663609
Market cap (USD): 12892360.90217391
Debt to equity: 0.5230886850152906
Current ratio: 0.5965986394557823
Quick ratio: 0.5965986394557823
Effective tax rate (%): -200
Interest coverage ratio: 1.7218934911242603
COGS to revenue (%): 59.9964377949951
SG&A to revenue (%): 6.278386321132781
Free cash flow (dilution-adjusted): 216304.34782608695
Buyback yield (%): 0
Retained earnings: 364130.4347826087
Receivables turnover: 10.116216216216216
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5150726297703963
FCF margin (%): 1.7721969899367709
Revenue growth (%): 5.712895987949719
Rule of 40 score: 7.48509297788649
Financial ratios for DTD2.DE — annual report dated 2024-06-30
Total revenue: 13670967.741935482
Gross profit: 6351612.903225807
Operating income: 2061290.322580645
Net income: 1327956.9892473118
Capital expenditures: 6451.612903225806
Operating cash flow: 3045161.2903225804
Depreciation & amortization: 1262365.5913978494
Net tangible assets: 2135483.870967742
Owner earnings: 2583870.9677419355
Return on net tangible assets (%): 120.99697885196375
Capex to operating income (%): 0.31298904538341155
Buffett classification: The Great
Stock price: 1.8817204301075268
P/E ratio: 8.799500202429149
Shares outstanding: 6209933
Book value: 15408602.150537632
P/B ratio: 0.7583658583391487
Market cap (USD): 11685357.795698924
Debt to equity: 0.4198883461270063
Current ratio: 0.862811028917283
Quick ratio: 0.862811028917283
Effective tax rate (%): 25.602409638554217
Interest coverage ratio: 8.157446808510638
COGS to revenue (%): 53.53940537989617
SG&A to revenue (%): 6.8192543652666355
Free cash flow (dilution-adjusted): 2958064.5161290322
Buyback yield (%): 0
Retained earnings: 1688172.0430107526
Receivables turnover: 9.683168316831681
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.457792688341804
FCF margin (%): 21.637564889098634
Revenue growth (%): 12.00721633788088
Rule of 40 score: 33.64478122697952
Financial ratios for DTD2.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 2980208.3333333335
Buffett classification: The Gruesome
Stock price: 2.0729166666666665
Shares outstanding: 6209933
Market cap (USD): 12872673.614583332
Buyback yield (%): 0
Retained earnings: 2505208.3333333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBR.AX — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 384022
Buffett classification: The Gruesome
Stock price: 0.6014492753623188
Shares outstanding: 753305590
Market cap (USD): 453075101.23188406
Buyback yield (%): 1.0818477966837925
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBR.AX — annual report dated 2022-12-31
Operating income: -26742522
Net income: -33088205
Capital expenditures: 730179
Depreciation & amortization: 652432
Net tangible assets: 43949093
Owner earnings: -33165952
Return on net tangible assets (%): -75.46447431804792
Buffett classification: The Gruesome
Stock price: 0.3108108108108108
Shares outstanding: 753305590
Book value: 43949093
P/B ratio: 5.327425556113665
Market cap (USD): 234135521.2162162
Debt to equity: 0.49115311662973343
Current ratio: 11.228249514557376
Quick ratio: 11.228249514557376
Interest coverage ratio: -17.52694300348343
Free cash flow (dilution-adjusted): -31086097
Buyback yield (%): 0.09111218959510235
Retained earnings: -276827680
Capitalized R&D asset: 13228782
ROCI (R&D-adjusted, %): -22.694185000439997
Rule of 40 score: 0
Financial ratios for EBR.AX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -34548947
Net income: -35036888
Capital expenditures: 354054
Operating cash flow: -32697514
Depreciation & amortization: 752257
Net tangible assets: 31056452
Owner earnings: -34638685
Return on net tangible assets (%): -111.53458547035572
Buffett classification: The Gruesome
Stock price: 0.4178082191780822
Shares outstanding: 753305590
Book value: 31056452
P/B ratio: 10.134360069681962
Market cap (USD): 314737267.05479455
Debt to equity: 1.3391513299716271
Current ratio: 11.534281551859275
Quick ratio: 11.534281551859275
Interest coverage ratio: -7.705401372205425
Free cash flow (dilution-adjusted): -34357379
Buyback yield (%): 0.017434223952401226
Retained earnings: -312659408
Receivables turnover: 0
Capitalized R&D asset: 36009309.94
ROCI (R&D-adjusted, %): -19.23406091886614
Rule of 40 score: 0
Financial ratios for EBR.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6
Shares outstanding: 753305590
Market cap (USD): 451983354
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBR.AX — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -38319000
Net income: -40799000
Capital expenditures: 273000
Operating cash flow: -41230000
Depreciation & amortization: 587000
Net tangible assets: 24356000
Owner earnings: -40485000
Return on net tangible assets (%): -166.22187551322057
Buffett classification: The Gruesome
Stock price: 0.6335403726708074
Shares outstanding: 753305590
Book value: 24356000
P/B ratio: 19.594740689095193
Market cap (USD): 477249504.2236025
Debt to equity: 1.6997043849564788
Current ratio: 7.741803770865858
Quick ratio: 7.574756815179536
Interest coverage ratio: -6.354726368159204
Free cash flow (dilution-adjusted): -43245000
Buyback yield (%): 0
Retained earnings: -353458000
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 49618335.480000004
ROCI (R&D-adjusted, %): -29.371827379294484
Rule of 40 score: 0
Financial ratios for EBR.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 90641
Buffett classification: The Gruesome
Stock price: 0.6335403726708074
Shares outstanding: 753305590
Market cap (USD): 477249504.2236025
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBR.AX — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -9782000
Net income: -10554000
Capital expenditures: 60000
Operating cash flow: -13564000
Depreciation & amortization: 79000
Net tangible assets: 14558760
Owner earnings: -10535000
Return on net tangible assets (%): -72.36193192277365
Buffett classification: The Gruesome
Stock price: 1.10062893081761
Shares outstanding: 753305590
Book value: 14558760
P/B ratio: 56.949213126710575
Market cap (USD): 829109926.100629
Debt to equity: 3.755641689264745
Current ratio: 7.949947077519541
Quick ratio: 7.469433253751401
Interest coverage ratio: -7.002147458840372
Free cash flow (dilution-adjusted): -14129000
Buyback yield (%): 0
Retained earnings: -364011951
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 5419000
ROCI (R&D-adjusted, %): -8.315243702167722
Rule of 40 score: 0
Financial ratios for EBR.AX — quarterly report dated 2025-06-30
Total revenue: 169704
Gross profit: 84429
Operating income: -11131934
Net income: -11967441
Capital expenditures: 888793
Operating cash flow: -11476233
Depreciation & amortization: 118329
Net tangible assets: 49696129
Owner earnings: -12737905
Return on net tangible assets (%): -25.631583900629362
Buffett classification: The Gruesome
Stock price: 0.7843137254901961
Shares outstanding: 753305590
Book value: 49696129
P/B ratio: 11.888811575756538
Market cap (USD): 590827913.7254902
Debt to equity: 1.1305666886046597
Current ratio: 9.325675570639403
Quick ratio: 8.795742943192414
Interest coverage ratio: -7.779417406794241
COGS to revenue (%): 50.24925753075944
R&D to revenue (%): 3507.0228161976147
SG&A to revenue (%): 3102.3458492433883
Free cash flow (dilution-adjusted): -13068859
Buyback yield (%): 0
Retained earnings: -375979392
Inventory turnover: 0.016610286164405894
Receivables turnover: 0.08089301495508328
Capitalized R&D asset: 9582288
ROCI (R&D-adjusted, %): -7.812388457817308
Rosenberg metric: 0.015580180845174386
FCF margin (%): -7700.972870409654
Rule of 40 score: -7700.972870409654
Financial ratios for EBR.AX — quarterly report dated 2025-09-30
Total revenue: 512093
Gross profit: 223722
Operating income: -11880824
Net income: -12188854
Capital expenditures: 1277624
Operating cash flow: -13140971
Depreciation & amortization: 90217
Net tangible assets: 38650515
Owner earnings: -13376261
Return on net tangible assets (%): -34.60823484499495
Buffett classification: The Gruesome
Stock price: 0.7434210526315789
Shares outstanding: 753305590
Book value: 38650515
P/B ratio: 14.4894119695702
Market cap (USD): 560023234.6710526
Debt to equity: 1.4695382972257938
Current ratio: 7.9444375367544655
Quick ratio: 7.008337436887625
Interest coverage ratio: -8.334747382769175
COGS to revenue (%): 56.31223234842109
R&D to revenue (%): 1219.2968855266524
SG&A to revenue (%): 1144.442903925654
Free cash flow (dilution-adjusted): -15347898
Buyback yield (%): 0
Retained earnings: -388168246
Inventory turnover: 0.029761587158049198
Receivables turnover: 0.1890009607034283
Capitalized R&D asset: 12019747.86
ROCI (R&D-adjusted, %): -10.789734998794598
Rosenberg metric: 0.023404459806995077
FCF margin (%): -2997.0919344728395
Revenue growth (%): 201.7565879413567
Rule of 40 score: -2795.3353465314826
Financial ratios for EBR.AX — annual report dated 2025-12-31
Total revenue: 1617000
Gross profit: 490000
Operating income: -46087000
Net income: -48758000
Capital expenditures: 3683000
Operating cash flow: -53192000
Depreciation & amortization: 403000
Net tangible assets: 25588000
Owner earnings: -52038000
Return on net tangible assets (%): -203.36876660934814
Buffett classification: The Gruesome
Stock price: 0.5973154362416108
Shares outstanding: 753305590
Book value: 25588000
P/B ratio: 17.584846690405424
Market cap (USD): 449961057.11409396
Debt to equity: 2.2896670314209784
Current ratio: 5.204370728929385
Quick ratio: 4.2228075170842825
Interest coverage ratio: -8.16566265060241
COGS to revenue (%): 69.6969696969697
R&D to revenue (%): 1480.5194805194806
SG&A to revenue (%): 1399.9381570810142
Free cash flow (dilution-adjusted): -59926000
Buyback yield (%): 0
Retained earnings: -402216000
Inventory turnover: 0.08173181521502647
Receivables turnover: 0.6969827586206897
Capitalized R&D asset: 51031738.58
ROCI (R&D-adjusted, %): -35.91195580138206
Rosenberg metric: 0.018104563088860152
FCF margin (%): -3705.9987631416207
Rule of 40 score: -3705.9987631416207
Financial ratios for EBR.AX — quarterly report dated 2025-12-31
Total revenue: 935203
Gross profit: 181849
Operating income: -13292556
Net income: -14047434
Capital expenditures: 1456583
Operating cash flow: -15010796
Depreciation & amortization: 115454
Net tangible assets: 25588000
Owner earnings: -15388563
Return on net tangible assets (%): -60.139764733468816
Buffett classification: The Gruesome
Stock price: 0.5973154362416108
Shares outstanding: 753305590
Book value: 25588000
P/B ratio: 17.584846690405424
Market cap (USD): 449961057.11409396
Debt to equity: 2.2896670314209784
Current ratio: 5.204370728929385
Quick ratio: 4.2228075170842825
Interest coverage ratio: -9.55941374449846
COGS to revenue (%): 80.55513081117148
R&D to revenue (%): 676.4120731007065
SG&A to revenue (%): 764.387945718737
Free cash flow (dilution-adjusted): -17380243
Buyback yield (%): 0
Retained earnings: -402216000
Inventory turnover: 0.05463441873957502
Receivables turnover: 0.40310474137931035
Capitalized R&D asset: 12473275.920000002
ROCI (R&D-adjusted, %): -13.737927215583627
Rosenberg metric: -0.00670618875856151
FCF margin (%): -1858.4460272261745
Revenue growth (%): 82.62366406102016
Rule of 40 score: -1775.8223631651542
Financial ratios for ESK.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.33333333333333337
Shares outstanding: 141569695
Market cap (USD): 47189898.333333336
Buyback yield (%): 0.006142311865482965
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESK.AX — annual report dated 2022-12-31
Total revenue: 6541216.216216216
Gross profit: 4399324.324324325
Operating income: 435135.13513513515
Net income: 1481756.7567567567
Capital expenditures: 98648.64864864865
Depreciation & amortization: 857432.4324324324
Net tangible assets: 1071621.6216216215
Owner earnings: 2240540.5405405406
Return on net tangible assets (%): 209.07944514501895
Capex to operating income (%): 22.67080745341615
Buffett classification: The Great
Stock price: 0.31756756756756754
P/E ratio: 30.340974304605563
Shares outstanding: 141569695
Book value: 5844594.594594595
P/B ratio: 7.6922262023121375
Market cap (USD): 44957943.68243243
Debt to equity: 0.058497109826589594
Current ratio: 1.266221168355249
Quick ratio: 1.173313214054753
Effective tax rate (%): -4.528122020972354
Interest coverage ratio: 28.000000000000004
COGS to revenue (%): 32.74455118272906
SG&A to revenue (%): 47.4950934820783
Free cash flow (dilution-adjusted): -362837.83783783787
Buyback yield (%): 0.001502906094745832
Retained earnings: -6304054.054054054
Inventory turnover: 7.354988399071926
Receivables turnover: 2.925657298277425
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.998478591610518
FCF margin (%): -5.546947629377131
Rule of 40 score: -5.546947629377131
Financial ratios for ESK.AX — annual report dated 2023-12-31
Total revenue: 6451369.863013699
Gross profit: 3531506.8493150687
Operating income: -1136986.301369863
Net income: 179452.05479452055
Capital expenditures: 72602.7397260274
Depreciation & amortization: 1438356.1643835616
Net tangible assets: 1019178.0821917808
Owner earnings: 1545205.4794520547
Return on net tangible assets (%): 151.61290322580646
Buffett classification: The Gruesome
Stock price: 0.19863013698630136
P/E ratio: 156.69928072519085
Shares outstanding: 141569695
Book value: 6605479.452054795
P/B ratio: 4.257072952094566
Market cap (USD): 28120007.9109589
Debt to equity: 0.27975943591870595
Current ratio: 1.709095593919093
Quick ratio: 1.6335995877351202
Effective tax rate (%): -279.71014492753625
Interest coverage ratio: -13.28
COGS to revenue (%): 45.25958169657076
SG&A to revenue (%): 49.96284106593057
Free cash flow (dilution-adjusted): -1429452.0547945206
Buyback yield (%): 0.009742977441800565
Retained earnings: -6085616.438356165
Inventory turnover: 14.549488054607506
Receivables turnover: 2.2012152372049543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.302347944546842
FCF margin (%): -22.15734154368829
Revenue growth (%): -1.373542017763923
Rule of 40 score: -23.530883561452214
Financial ratios for ESK.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1521739.1304347825
Buffett classification: The Gruesome
Stock price: 0.13664596273291924
Shares outstanding: 141569695
Book value: 3924223.602484471
P/B ratio: 4.929619009180121
Market cap (USD): 19344927.267080743
Debt to equity: 0.5234251345362457
Current ratio: 0.8964848484848483
Quick ratio: 0.8390303030303029
Buyback yield (%): 0
Retained earnings: -7555279.503105589
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESK.AX — annual report dated 2024-12-31
Total revenue: 3684472.049689441
Gross profit: 870186.3354037267
Operating income: -3834782.608695652
Net income: -2418633.5403726706
Capital expenditures: 55900.621118012416
Depreciation & amortization: 1509937.8881987578
Net tangible assets: -1521739.1304347825
Owner earnings: -964596.2732919253
Buffett classification: The Gruesome
Stock price: 0.13664596273291924
Shares outstanding: 141569695
Book value: 3924223.602484471
P/B ratio: 4.929619009180121
Market cap (USD): 19344927.267080743
Debt to equity: 0.5234251345362457
Current ratio: 0.8964848484848483
Quick ratio: 0.8390303030303029
Interest coverage ratio: -27.936651583710407
COGS to revenue (%): 76.38233310856371
SG&A to revenue (%): 86.71611598111934
Free cash flow (dilution-adjusted): -1057142.857142857
Buyback yield (%): 0
Retained earnings: -7555279.503105589
Inventory turnover: 19.11814345991561
Receivables turnover: 1.78406015037594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.12546738678854
FCF margin (%): -28.691840863115303
Revenue growth (%): -42.88853177039405
Rule of 40 score: -71.58037263350936
Financial ratios for EWTX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.28
Shares outstanding: 107593006
Market cap (USD): 1644021131.6799998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EWTX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -71658000
Net income: -67640000
Capital expenditures: 5546000
Operating cash flow: -52635000
Depreciation & amortization: 538000
Net tangible assets: 346716000
Owner earnings: -72648000
Return on net tangible assets (%): -20.953172048593085
Buffett classification: The Gruesome
Stock price: 8.94
Shares outstanding: 107593006
Book value: 346716000
P/B ratio: 2.774263298030665
Market cap (USD): 961881473.64
Debt to equity: 0.012713575375811904
Current ratio: 21.525414531202895
Quick ratio: 21.525414531202895
Free cash flow (dilution-adjusted): -69105000
Buyback yield (%): 0
Retained earnings: -144600000
Capitalized R&D asset: 54032000
ROCI (R&D-adjusted, %): -8.80900824294439
Rule of 40 score: 0
Financial ratios for EWTX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -114357000
Net income: -100163000
Capital expenditures: 5745000
Operating cash flow: -91948000
Depreciation & amortization: 1732000
Net tangible assets: 318830000
Owner earnings: -104176000
Return on net tangible assets (%): -32.674466016372364
Buffett classification: The Gruesome
Stock price: 10.94
Shares outstanding: 107593006
Book value: 318830000
P/B ratio: 3.6918341612771695
Market cap (USD): 1177067485.6399999
Debt to equity: 0.016980836182291504
Current ratio: 19.497763997376424
Quick ratio: 19.497763997376424
Free cash flow (dilution-adjusted): -115253000
Buyback yield (%): 0
Retained earnings: -244763000
Capitalized R&D asset: 127106440
ROCI (R&D-adjusted, %): -15.934512339072107
Rule of 40 score: 0
Financial ratios for EWTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.69
Shares outstanding: 107593006
Market cap (USD): 2871657330.1400003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EWTX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -158832000
Net income: -133813000
Capital expenditures: 1312000
Operating cash flow: -109028000
Depreciation & amortization: 2290000
Net tangible assets: 459216000
Owner earnings: -132835000
Return on net tangible assets (%): -28.926474687293123
Buffett classification: The Gruesome
Stock price: 26.7
Shares outstanding: 107593006
Book value: 459216000
P/B ratio: 6.255734251855336
Market cap (USD): 2872733260.2
Debt to equity: 0.010315407128671475
Current ratio: 19.928038558256496
Quick ratio: 19.928038558256496
Free cash flow (dilution-adjusted): -135052000
Buyback yield (%): 0
Retained earnings: -378576000
Capitalized R&D asset: 205702910
ROCI (R&D-adjusted, %): -18.320274851431325
Rule of 40 score: 0
Financial ratios for EWTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.7
Shares outstanding: 107593006
Market cap (USD): 2872733260.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EWTX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -45959000
Net income: -40798000
Capital expenditures: 44000
Operating cash flow: -37866000
Depreciation & amortization: 554000
Net tangible assets: 429719000
Owner earnings: -40288000
Return on net tangible assets (%): -9.375429059455133
Buffett classification: The Gruesome
Stock price: 22
Shares outstanding: 107593006
Book value: 429719000
P/B ratio: 5.508358094475692
Market cap (USD): 2367046132
Debt to equity: 0.010606931506403022
Current ratio: 20.98877575183519
Quick ratio: 20.98877575183519
Free cash flow (dilution-adjusted): -46969000
Buyback yield (%): 0
Retained earnings: -419374000
Capitalized R&D asset: 36757000
ROCI (R&D-adjusted, %): -4.564431291703633
Rule of 40 score: 0
Financial ratios for EWTX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -42610000
Net income: -36115000
Capital expenditures: 50000
Operating cash flow: -32582000
Depreciation & amortization: 567000
Net tangible assets: 589071000
Owner earnings: -35598000
Return on net tangible assets (%): -6.043074603910225
Buffett classification: The Gruesome
Stock price: 13.11
Shares outstanding: 107593006
Book value: 589071000
P/B ratio: 2.394523425291688
Market cap (USD): 1410544308.6599998
Debt to equity: 0.007420158181271867
Current ratio: 28.86940084226646
Quick ratio: 28.86940084226646
Free cash flow (dilution-adjusted): -40365000
Buyback yield (%): 0
Retained earnings: -455489000
Capitalized R&D asset: 58185190
ROCI (R&D-adjusted, %): -4.993725067397818
Rule of 40 score: 0
Financial ratios for EWTX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -46858000
Net income: -40666000
Capital expenditures: 89000
Operating cash flow: -34776000
Depreciation & amortization: 570000
Net tangible assets: 558647000
Owner earnings: -40185000
Return on net tangible assets (%): -7.193272316865571
Buffett classification: The Gruesome
Stock price: 16.22
Shares outstanding: 107593006
Book value: 558647000
P/B ratio: 3.1239021373425433
Market cap (USD): 1745158557.32
Debt to equity: 0.007484153678440948
Current ratio: 26.512981613231084
Quick ratio: 26.512981613231084
Free cash flow (dilution-adjusted): -42950000
Buyback yield (%): 0
Retained earnings: -496155000
Capitalized R&D asset: 72093670
ROCI (R&D-adjusted, %): -7.147608390692484
Rule of 40 score: 0
Financial ratios for EWTX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -191406000
Net income: -167795000
Capital expenditures: 256000
Operating cash flow: -143816000
Depreciation & amortization: 2266000
Net tangible assets: 522257000
Owner earnings: -165785000
Return on net tangible assets (%): -31.74394981781001
Buffett classification: The Gruesome
Stock price: 24.82
Shares outstanding: 107593006
Book value: 522257000
P/B ratio: 5.11330323752482
Market cap (USD): 2670458408.92
Debt to equity: 0.007639916745969896
Current ratio: 19.853306540007306
Quick ratio: 19.853306540007306
Free cash flow (dilution-adjusted): -178824000
Buyback yield (%): 0
Retained earnings: -546371000
Capitalized R&D asset: 266454870
ROCI (R&D-adjusted, %): -20.60201663398818
Rule of 40 score: 0
Financial ratios for EWTX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -55979000
Net income: -50216000
Capital expenditures: 73000
Operating cash flow: -38592000
Depreciation & amortization: 575000
Net tangible assets: 522257000
Owner earnings: -49714000
Return on net tangible assets (%): -9.519068198224245
Buffett classification: The Gruesome
Stock price: 24.82
Shares outstanding: 107593006
Book value: 522257000
P/B ratio: 5.11330323752482
Market cap (USD): 2670458408.92
Debt to equity: 0.007639916745969896
Current ratio: 19.853306540007306
Quick ratio: 19.853306540007306
Free cash flow (dilution-adjusted): -48540000
Buyback yield (%): 0
Retained earnings: -546371000
Capitalized R&D asset: 79779740
ROCI (R&D-adjusted, %): -8.362744008773545
Rule of 40 score: 0
Financial ratios for FMR.TO — annual report dated 2021-07-31
Capital expenditures: 276083.06451612903
Buffett classification: The Gruesome
Stock price: 0.9274193548387096
Shares outstanding: 17520931
Market cap (USD): 16249250.524193548
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FMR.TO — annual report dated 2022-07-31
Total revenue: 0
Operating income: -8260951.5625
Net income: -9420178.125
Capital expenditures: 0
Operating cash flow: -4445825.78125
Net tangible assets: 6554211.71875
Owner earnings: -9420178.125
Return on net tangible assets (%): -143.72709532789688
Buffett classification: The Gruesome
Stock price: 0.546875
Shares outstanding: 17520931
Book value: 6554211.71875
P/B ratio: 1.4619239584851866
Market cap (USD): 9581759.140625
Debt to equity: 0.023839632698011096
Current ratio: 12.675250013220849
Quick ratio: 12.675250013220849
Free cash flow (dilution-adjusted): -4786442.96875
Buyback yield (%): 0
Retained earnings: -22639922.65625
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -126.04035263107893
Rule of 40 score: 0
Financial ratios for FMR.TO — annual report dated 2023-07-31
Total revenue: 0
Operating income: -1456836.0902255639
Net income: -4272422.556390977
Capital expenditures: 0
Operating cash flow: -1037878.1954887217
Net tangible assets: 2035390.2255639096
Owner earnings: -4272422.556390977
Return on net tangible assets (%): -209.90680326212595
Buffett classification: The Gruesome
Stock price: 0.37593984962406013
Shares outstanding: 17520931
Book value: 2035390.2255639099
P/B ratio: 3.2361441470461223
Market cap (USD): 6586816.165413533
Debt to equity: 0.03360682716251414
Current ratio: 4.542073977345436
Quick ratio: 4.542073977345436
Interest coverage ratio: -1985.237704918033
Free cash flow (dilution-adjusted): -1037124.8120300751
Buyback yield (%): 0
Retained earnings: -25962990.97744361
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -71.5752720008245
Rule of 40 score: 0
Financial ratios for FMR.TO — annual report dated 2024-07-31
Total revenue: 0
Operating income: -1524896.3768115942
Net income: -1890639.1304347827
Capital expenditures: 0
Operating cash flow: -357776.0869565218
Net tangible assets: 228207.97101449277
Owner earnings: -1890639.1304347827
Return on net tangible assets (%): -828.4719950972765
Buffett classification: The Gruesome
Stock price: 0.10869565217391305
Shares outstanding: 17520931
Book value: 228207.97101449268
P/B ratio: 8.345234451158525
Market cap (USD): 1904449.0217391306
Debt to equity: 0.4730493098400584
Current ratio: 1.15154447586179
Quick ratio: 1.15154447586179
Interest coverage ratio: -139.94526833809934
Free cash flow (dilution-adjusted): -513711.5942028986
Buyback yield (%): 0
Retained earnings: -26847702.898550726
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -668.2046950563149
Rule of 40 score: 0
Financial ratios for FMR.TO — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.10791366906474821
Shares outstanding: 17520931
Market cap (USD): 1890747.949640288
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FMR.TO — quarterly report dated 2025-01-31
Total revenue: 0
Operating income: -223526.20689655174
Net income: -1447883.448275862
Capital expenditures: 0
Operating cash flow: 3278.6206896551726
Net tangible assets: -782780
Owner earnings: -1447883.448275862
Buffett classification: The Gruesome
Stock price: 0.06896551724137931
Shares outstanding: 17520931
Book value: -782780
Market cap (USD): 1208340.0689655172
Debt to equity: -0.13834159595641
Current ratio: 0.5499302113485863
Quick ratio: 0.5499302113485863
Interest coverage ratio: -80.5650012428536
Free cash flow (dilution-adjusted): 3450.344827586207
Buyback yield (%): 0
Retained earnings: -26522750.34482759
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FMR.TO — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -242968.115942029
Net income: -147151.44927536233
Capital expenditures: 0
Operating cash flow: -52794.92753623189
Net tangible assets: -942489.1304347827
Owner earnings: -147151.44927536233
Buffett classification: The Gruesome
Stock price: 0.10869565217391305
Shares outstanding: 17520931
Book value: -942489.1304347827
Market cap (USD): 1904449.0217391306
Debt to equity: -0.12371956774959922
Current ratio: 0.5212328933525826
Quick ratio: 0.5212328933525826
Interest coverage ratio: -86.15005138746146
Free cash flow (dilution-adjusted): -80123.91304347827
Buyback yield (%): 0
Retained earnings: -28015258.695652176
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FMR.TO — quarterly report dated 2025-07-31
Total revenue: 0
Operating income: -308276.0869565218
Net income: -696919.5652173914
Capital expenditures: 0
Operating cash flow: -99353.6231884058
Net tangible assets: -1639408.695652174
Owner earnings: -696919.5652173914
Buffett classification: The Gruesome
Stock price: 0.1449275362318841
Shares outstanding: 17520931
Book value: -1639408.6956521738
Market cap (USD): 2539265.3623188413
Debt to equity: -0.11775896576354855
Current ratio: 0.29261178578693947
Quick ratio: 0.29261178578693947
Interest coverage ratio: -37.25880189174987
Free cash flow (dilution-adjusted): -99534.0579710145
Buyback yield (%): 0
Retained earnings: -28712178.260869566
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FMR.TO — annual report dated 2025-07-31
Total revenue: 0
Operating income: -1038366.6666666667
Net income: -1894765.2173913044
Capital expenditures: 0
Operating cash flow: -184342.02898550726
Net tangible assets: -1639408.695652174
Owner earnings: -1894765.2173913044
Buffett classification: The Gruesome
Stock price: 0.1449275362318841
Shares outstanding: 17520931
Book value: -1639408.6956521738
Market cap (USD): 2539265.3623188413
Debt to equity: -0.11775896576354855
Current ratio: 0.29261178578693947
Quick ratio: 0.29261178578693947
Interest coverage ratio: -60.841796875
Free cash flow (dilution-adjusted): -211671.01449275363
Buyback yield (%): 0
Retained earnings: -28712178.260869566
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FMR.TO — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -114685.71428571429
Net income: 931780.0000000001
Capital expenditures: 0
Operating cash flow: -164723.57142857145
Net tangible assets: -35994.28571428572
Owner earnings: 931780.0000000001
Return on net tangible assets (%): -2588.688680742975
Buffett classification: The Gruesome
Stock price: 0.3
P/E ratio: 1.4102790626542745
Shares outstanding: 17520931
Book value: -35994.2857142858
Market cap (USD): 5256279.3
Debt to equity: -5.426714557866315
Current ratio: 1.3008979552195923
Quick ratio: 1.3008979552195923
Interest coverage ratio: -37.76993648553282
Free cash flow (dilution-adjusted): -165510.00000000003
Buyback yield (%): 0
Retained earnings: -27370224.285714287
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -71.97708352945925
Rule of 40 score: 0
Financial ratios for FMR.TO — quarterly report dated 2026-01-31
Total revenue: 0
Operating income: -331667.40740740736
Net income: -335682.2222222222
Capital expenditures: 0
Operating cash flow: -70718.51851851851
Net tangible assets: -160525.92592592593
Owner earnings: -335682.2222222222
Buffett classification: The Gruesome
Stock price: 0.23703703703703702
Shares outstanding: 17520931
Book value: -160525.92592592584
Market cap (USD): 4153109.57037037
Debt to equity: -2.90872594711827
Current ratio: 1.9284702597265588
Quick ratio: 1.9284702597265588
Interest coverage ratio: -63.53781751099758
Free cash flow (dilution-adjusted): -282831.1111111111
Buyback yield (%): 0
Retained earnings: -28719618.518518515
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -108.24654288753504
Rule of 40 score: 0
Financial ratios for GH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 100.02
Shares outstanding: 132599929
Market cap (USD): 13262644898.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GH — annual report dated 2022-12-31
Total revenue: 449538000
Gross profit: 293213000
Operating income: -544378000
Net income: -654588000
Capital expenditures: 77461000
Operating cash flow: -309463000
Depreciation & amortization: 35962000
Net tangible assets: 45163000
Owner earnings: -696087000
Return on net tangible assets (%): -1541.2771516506875
Buffett classification: The Gruesome
Stock price: 27.2
Shares outstanding: 132599929
Book value: 60180000
P/B ratio: 59.93217129943503
Market cap (USD): 3606718068.7999997
Debt to equity: 22.753140578265203
Current ratio: 6.167032398302453
Quick ratio: 5.899989649104648
Interest coverage ratio: -211.24485836243693
COGS to revenue (%): 34.77459080211239
R&D to revenue (%): 83.15359324462003
SG&A to revenue (%): 103.16903131659616
Free cash flow (dilution-adjusted): -481609000
Buyback yield (%): 0
Retained earnings: -1662413000
Inventory turnover: 3.0296716927012675
Receivables turnover: 4.622213539524553
Capitalized R&D asset: 373807000
ROCI (R&D-adjusted, %): -16.48486256533294
FCF margin (%): -107.1342133479261
Rule of 40 score: -107.1342133479261